SCHEMBL9106400

SCHEMBL9106400

Cc1ccc2c(c1)N(C(CC1CCCC1)C(=O)O)C(=O)C2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 1/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 1/20 0.37
GCK P35557 6/20 0.36
NAMPT P43490 1/20 0.36
OPRM1 P35372 1/20 0.36
OPRD1 P41143 1/20 0.36
OPRK1 P41145 1/20 0.36
OPRL1 P41146 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CHRM2 P08172 3/20 0.36
CHRM4 P08173 3/20 0.36
CHRM5 P08912 3/20 0.36
CHRM1 P11229 3/20 0.36
CHRM3 P20309 3/20 0.36
GAA P10253 1/20 0.36
PKM P14618 1/20 0.36
HTT P42858 1/20 0.36
CCKBR P32239 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9107495 0.91 PDE5A (0.45) PDE5ANPC1RAB9AGCKNAMPT
SCHEMBL9104376 0.86 GRN (0.39) GCKNAMPT
SCHEMBL9108554 0.86 NAMPT (0.37) NPC1RAB9ANAMPTOPRM1OPRK1
SCHEMBL9104327 0.86 CCR5 (0.38) NPC1RAB9AGCKNAMPTCHRM2
SCHEMBL9105977 0.85 HTR2A (0.36) RAB9AOPRM1OPRK1OPRL1CCKBR
SCHEMBL9106741 0.84 OPRM1 (0.44) OPRM1OPRK1OPRL1PKMCCKBR
SCHEMBL9105143 0.80 GCK (0.53) NPC1RAB9AGCK
SCHEMBL9104469 0.80 GCK (0.53) GCK
SCHEMBL9908122 0.80 GCK (0.52) NPC1RAB9AGCK
SCHEMBL9106271 0.80 GCK (0.61) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS GPR119, INSR, OAT PDE5A 2140/4885NPC1 2165/4885RAB9A 1778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.